http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170118830-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a80cbaaeee718664126e579cf4e41c2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-423 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-423 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate | 2016-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0dbcc7f4b4d5333f54cf6c92b6eee7e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0170e968988c087246e3708e633c23a4 |
| publicationDate | 2017-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20170118830-A |
| titleOfInvention | Iloperidone for the treatment of schizophrenia |
| abstract | Aspects of the present invention generally relate to the treatment of individuals with asthma, and more particularly to the treatment of individuals with iroperidone, iroperidone metabolites or pharmaceutically acceptable salts thereof. In one embodiment, the present invention provides a method of preventing the recurrence of asthma in an individual diagnosed with asthma, said method comprising administering to a subject an effective amount of at least one compound selected from the group consisting of Ilroperidone, Comprising the step of administering the pharmaceutically acceptable salt thereof after a time when the individual's asthma is stabilized. |
| priorityDate | 2015-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.